Oramed Pharmaceuticals In... (ORMP)
NASDAQ: ORMP
· Real-Time Price · USD
2.08
-0.04 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
2.07
-0.48%
After-hours: Aug 15, 2025, 05:49 PM EDT
Oramed Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
PE Ratio | -1.27 | 2.85 | 18.81 | 1.75 | -8.19 | -30.15 | -12.14 | -13.73 | -8.73 | -4.22 | -8.02 | -22.33 | -21.49 | -16.77 | -13.24 |
PEG Ratio | 0.00 | 0.01 | -0.21 | -0.00 | -0.05 | 0.89 | 0.15 | -0.87 | 0.29 | n/a | -0.35 | 5.14 | -0.61 | n/a | 0.51 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 213.66 | 131.07 | 688.90 | 371.51 | 263.62 | 502.37 | 1.05K | 862.39 | 512.89 | 367.10 |
PB Ratio | 0.64 | 0.59 | 0.69 | 0.57 | 0.71 | 0.95 | 0.58 | 3.09 | 1.65 | 1.16 | 2.06 | 4.14 | 5.09 | 5.13 | 4.94 |
P/FCF Ratio | -14.04 | 50.51 | -78.19 | -65.64 | -145.4 | -54.26 | -15.19 | -56.05 | -107.27 | -20.88 | -36.48 | -102.11 | -95.48 | -61.93 | -74.38 |
P/OCF Ratio | -14.05 | 50.51 | -78.3 | -65.78 | -152.11 | -54.67 | -15.73 | -58.19 | -113.06 | -20.93 | -36.67 | -102.11 | -95.9 | -61.95 | -75.14 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -3.91 | -8.33 | -11.84 | -3.29 | -12.6 | -13.7 | -10.24 | -8.99 | -8.28 | -4.89 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.20 | 0.32 | 0.51 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
Quick Ratio | 27.08 | 41.06 | 5.28 | 3.06 | 2.25 | 141.49 | 31.21 | 27.34 | 24.55 | 21.01 | 22.70 | 19.89 | 14.27 | 12.56 | 9.69 |
Current Ratio | 27.08 | 41.06 | 5.28 | 3.06 | 2.25 | 141.49 | 31.21 | 27.34 | 24.55 | 21.01 | 22.70 | 19.89 | 14.27 | 12.56 | 9.69 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Interest Coverage | -0.2 | -12.01 | -5 | -3.2 | -3.5 | n/a | n/a | n/a | -7.9 | -32.62 | -20.68 | -46.06 | n/a | -12.41 | -18.72 |
Return on Equity | -0.13 | 0.05 | 0.01 | 0.08 | -0.02 | -0.01 | -0.01 | -0.06 | -0.05 | -0.07 | -0.06 | -0.05 | -0.06 | -0.08 | -0.09 |
Return on Assets | -0.12 | 0.05 | 0.01 | 0.06 | -0.01 | -0.01 | -0.01 | -0.05 | -0.04 | -0.06 | -0.06 | -0.04 | -0.05 | -0.06 | -0.07 |
Return on Invested Capital | -0.02 | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 | -0.02 | -0.06 | -0.05 | -0.07 | -0.07 | -0.04 | -0.06 | -0.08 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -1.77 | -2.7 | -12.54 | -10.63 | -15.63 | -15.65 | -11.71 | -10.03 | -7.65 | -6.93 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -1.95 | -5.42 | -12.83 | -10.49 | -16.42 | -16.08 | -12.01 | -10.52 | -8.26 | -6.93 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.62 | -7.82 | -14.3 | -12.01 | -16.94 | -16.89 | -11.96 | -10.85 | -8.98 | -7.32 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -5.55 | -7.76 | -9.97 | -11.99 | -16.92 | -16.88 | -11.74 | -10.82 | -8.94 | -7.28 |